FAF1 and Miyoshi myopathy: In this study, we investigated 233 MM during diagnosis with a combination of four probes targeting 17p13/TP53 deletion, t(4;14)(p16;q32) translocation, 1p32/CDKN2C-FAF1 deletion, and 1q21/CKS1B gain.